Reconstruction of Extensive Upper Extremity Long Bone Defects With a Microvascular Fibula Flap
1 other identifier
observational
13
0 countries
N/A
Brief Summary
This study assesses the long-term functional outcomes of upper extremity long bone defects treated with the free fibula bone transfer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2014
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 21, 2015
CompletedFirst Posted
Study publicly available on registry
February 26, 2015
CompletedAugust 19, 2015
August 1, 2015
8 months
February 21, 2015
August 17, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The long-term results are good
The long-term outcomes are assessed and good results gained.
10-20 years
Secondary Outcomes (3)
Disabilities of the Arm, Shoulder and Hand questionnaire
10-20 years
the 15-Dimensions health-related quality of life instrument
10-20 years
Lower Extremity Functional Scale
10-20 years
Interventions
Reconstructive surgery with a microvascular bone flap
Eligibility Criteria
Twenty patients with upper extremity long bone bone defect treated with a microvascular fibula transfer. Population aged below 90 years.
You may qualify if:
- All patients of upper extremity long bone bone defect treated with a microvascular fibula transfer in Helsinki University Central Hospital.
You may not qualify if:
- No upper extremity free fibular transfer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Erkki J. Tukiainen, MD, PhD
Helsinki University Central Hospital
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.S.
Study Record Dates
First Submitted
February 21, 2015
First Posted
February 26, 2015
Study Start
June 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
August 19, 2015
Record last verified: 2015-08